According to Novo Nordisk, a 64-week clinical trial with over 300 participants found that those with obesity or overweight who took the oral Wegovy pill once a day lost an average of 16.6% of their body weight for people who completed the trial, a similar amount to those who took the injectable form of Wegovy, which launched in 2021, on a weekly basis
Alpha Lipoic Acid Helps protect skin from damage and supports anti-aging benefits
IV therapy bypasses digestion and increases circulating levels temporarily
Found has increasingly centered its service on GLP-1 receptor agonists, which, at this point in the research, appear to be very safe.6 Weve stayed on top of the latest research as its come out, and it seems like the scientific community is finding more benefits to the drug than drawbacks.16 We keep waiting for the other shoe to drop, and there is no long-term data on what decades of use might do, but the side effect profile seems very low for now
Curious to know more
If you are prone to sleep disturbances on GLP-1 therapy , evening injection might worsen the problem rather than solve it
